The Market at Work: CVS Selling Generic EpiPen at 1/6 The Cost
LISTEN TO TLR’S LATEST PODCAST: by Micah J. Fleck Mylan’s notoriously rising prices for its EpiPen product as of late has angered economic illiterates who assume this is a result of evil capitalism. But now, CVS Pharmacy is proving said critics wrong by utilizing capitalism itself to provide competition to the EpiPen that does the…